Duke Cancer Institute ( Site 0107)
Durham, North Carolina 27710
0 studies enrolling now · 1 studies all time
What they study most
Bladder Cancer
Studies at this site
A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)
— Running, not enrolling